http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007054750-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8f3143079517e9d28f1bec7edfeed03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a516ec9403570d7edc4b63e4f86c54a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9885d6048ea964050e4f6139e2808153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3048c936f364a27691ba4ba48df65852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60ac3e46934805488d271bd88f867163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_928275d67b793a68cdc61f3847bf23a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6b3c2239c820ee4ff801857068e7625
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_044b6227c01845d21cc04506d036286e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
filingDate 2006-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f86368741d2a040e5fd35cc6d899905
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10284aadedbcd96b16046119f1700795
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c7eb26a1c3d7c33c2cd65bd528dce21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cb3582c89723d0b3e1e8292f690b42c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec0815b38bb8a4327418dd9559ff338e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e824877bbb0af4d0338816e6d8b788af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3f698b5f728b102cac7e256376876bb
publicationDate 2007-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007054750-A3
titleOfInvention Process for the preparation of olanzapine
abstract The invention relates to a process for the preparation of 2 -methyl-4 - (4-methylpiperazin- 1-yl) - 10H- thieno- [2 , 3 -b] [1 , 5] benzodiazepine (olanzapine) of the formula (I) by reacting 4-amino-2-methyl-10H-thieno [2,3- b] [1/5] benzodiazepine hydrochloride of the formula (II) with N-methylpiperazine in an organic solvent, which comprises carrying out the reaction in the mixture of toluene and 1, 3-dimethyl-2- imidazolidinone . The invention also encompasses new 2-methyl-4- (4-methylpiperazin-l-yl) -10H-thieno [2,3- b] [1,5] benzodiazepine dihydrochloride trihydrate of the formula (IB) , the preparation thereof and pharmaceutical compositions comprising said new compound.
priorityDate 2005-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0733635-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03101997-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005159408-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414857739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22414443
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424599094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450885992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227198030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140537143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451515585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516322

Total number of triples: 46.